Arena Pharmaceuticals | OTC Capital Partners
Thursday, February 9, 2012

Deerfield Invests Another $33M in Arena Pharmaceuticals to Fund Lorcaserin Clinical Trials

Posted by The PIPEs Report on January 11, 2012

Deerfield Management Co., a health-care-focused investment firm, is buying another $33 million in co…
Source >>>

Azimuth Provides Second $50M Equity Line to Arena Pharmaceuticals For Clinical Trials of Weight Loss Drug

Posted by The PIPEs Report on November 9, 2011

Azimuth Opportunity LP, a fund managed by Acqua Wellington Asset Management, is providing a second $…
Source >>>

Deerfield Invests $35.6M in Arena Pharmaceuticals to Fund Early Debt Repayment

Posted by The PIPEs Report on March 29, 2011

Deerfield Management Co. is investing $35.6 million in two private placements of Arena Pharmaceutica…
Source >>>

Arena Pharmaceuticals Drug Rejected by FDA Panel, NY Times Says

Posted by The PIPEs Report on September 16, 2010

An advisory panel of the Food and Drug Administration voted not to recommend approval of a weight lo…
Source >>>